Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 88
  • Start Date: January 13, 2021
FArial NErf MRI in the Preoperative Assessment of PArotide Tumors
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Radiation
  • Participants: 55
  • Start Date: December 24, 2020
A Phase II Study of Adjuvant Ado-trastuzumab Emtansine (T-DM1) in HER2-positive Salivary Gland Carcinomas
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 30
  • Start Date: August 25, 2020
Physiologic MR Imaging in Distinguishing Benign From Malignant Salivary Gland Tumors
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 64
  • Start Date: June 2, 2020
A Phase II Study of Lenvatinib Plus Pembrolizumab in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma and Other Salivary Gland Cancers
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 10
  • Start Date: May 26, 2020
Lutetium-177-PSMA Radioligand Therapy for Advanced Salivary Gland Cancer, a Phase II Pilot Study.
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 14
  • Start Date: January 14, 2020
Effect of Androgen Deprivation Therapy on Uptake of PSMA Ligand in Patients With Salivary Duct Carcinoma: an Explorative Study.
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Radiation
  • Participants: 314
  • Start Date: December 15, 2019
Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 62
  • Start Date: October 22, 2019
A Multicenter Phase I/II Trial of A Novel MDM2 Inhibitor (APG-115) With or Without Platinum Chemotherapy in P53 Wild-Type Salivary Gland Carcinoma
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Device
  • Participants: 50
  • Start Date: October 2019
Combined Role of Color Doppler and Diffusion Weighted MRI In Differentiation Between Benign and Malignant Tumors of Major Salivary Glands
Showing 1-12 of 34